| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.009 |